Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Supply of External Quality Control Materials

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract is for the supply of external quality control materials, specifically positive and negative controls, to support respiratory panel testing procedures, ensuring the accuracy and reliability of diagnostic assays in compliance with CLIA regulations. These materials are essential for maintaining the integrity of laboratory testing workflows and validating performance metrics for respiratory pathogen detection. The solicitation is issued as a subcontract under a Buy Indian Set-Aside designation, reserved exclusively for eligible Native American-owned businesses supporting the Department of Health and Human Services, specifically the Indian Health Services. The North American Industry Classification System code 325412 indicates the procurement relates to pharmaceutical and medicine manufacturing, with the place of performance centered in Oklahoma City, zip code 73114. The opportunity was posted on July 17, 2026, and responses are due by July 31, 2026, with no designated point of contact information provided publicly.

General Info

Supply of respiratory testing controls for Native-owned businesses under Buy Indian Set-Aside, performance in Oklahoma City.

Agency

Department Of Health And Human Services → Administration Services BranchView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Oklahoma City, OK, 73114, USA

Set-Aside

BICiv

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Administration Services Branch
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Administration Services Branch
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of positive and negative control materials for respiratory panel testing to ensure assay accuracy and CLIA compliance.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4353
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
Solicitation # SPE2DP-26-T-4359
Vecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials each, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life. The powder must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with containers retained in their outer cartons until use. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed and packaged in commercial shipping containers that ensure safe delivery via common carrier at the lowest rate. The product is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be sent by traceable means only; parcel post is prohibited. Deliveries are FOB destination with zero variance allowed, and inspection and acceptance occur upon arrival. The supplier is Hikma Pharmaceuticals USA Inc., with NDC 00143-9234-10, and the contract requires multiple deliveries across different locations and dates in July 2026, totaling eight line items for one or three packages per delivery. All packaging, palletization, and labeling must adhere to DLA Packaging Requirements for Procurement and specific storage and handling instructions.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4355
The contract specifies the procurement of 8 units (TU) of white petrolatum, USP, with each TU equaling 28 milligrams, for a total quantity of 224 milligrams. The material must comply with stringent packaging and marking requirements per the Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must be packaged in sealed commercial unit containers that protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months and must be shipped by the fastest traceable means, excluding parcel post. Delivery is required within five days of award under FOB destination terms with zero quantity variance permitted and acceptance occurring at the delivery point. The product must be commercially packaged per ASTM D3951 unless deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies; however, all DLA Master List of Technical and Quality Requirements override any conflicting standards. Packaging and labeling must reflect the specified unit of issue and quantity per unit pack, and palletization must adhere to DLA packaging guidelines. The delivery address is for the 0182 IN BN 01 HHC INFANTRY BN in Melrose, MA, with the required delivery date set for July 30, 2026, and the contract reference number is SPE2DP-26-T-4355.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TYPHOID VI POLYSACCHAR
Solicitation # SPE2DP-26-T-4363
The contract specifies the procurement of Typhoid Vi Polysaccharide Vaccine, a modified acellular vaccine supplied in 10 mL vials, with a total quantity of 10 vials, each containing 20 doses. The vaccine must adhere to the Medical Procurement Item Description (MPID) No. 3 dated 20 March 2006, with modifications including the substitution of “vial” for “box” in packaging references. The product must have a minimum shelf life of 18 months, with at least 15 months remaining at the time of delivery to the first government activity, and this shelf-life requirement is non-extendable. The vaccine requires constant refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit) throughout transport and storage, and all packaging, labeling, and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-129. Commercial packaging must conform to ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements, which take precedence. The product is to be delivered FOB destination within five days of the contract award, with no variance allowed in quantity. Delivery is directed to USS RALPH JOHNSON DDG 114 at FPO AP 96691-3300, with transportation governed by DLAD procedure notes C19 and C20. The contract is tied to NSN 6505-01-385-6328 and solicitation SPE2DP-26-T-4363, with an original required delivery date of 31 July 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
SUMATRIPTAN SUCCINA
Solicitation # SPE2DP-26-T-4365
Sumatriptan succinate tablets, 25 mg film-coated, are provided in bottles of nine tablets for the acute treatment of migraine with or without aura in adults and must be stored at controlled room temperature between 20 to 25 °C (68 to 77 °F) with protection from light. The contract specifies adherence to strict packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA packaging requirements and shelf life constrained to 24 months under Type I (Code M) non-extendable limits. Deliveries are scheduled for multiple military installations across Fort Bliss, Fort Hood, and Fort Bragg with firm delivery windows of 20 days and no variance allowed in quantity. Each shipment must be transported via traceable means excluding parcel post, with inspection and acceptance occurring at the destination. The contract includes multiple line items under solicitation SPE2DP-26-T-4365, totaling 54 units (nine-tablet bottles), with delivery dates ranging from April to July 2026, and all items carry the same NSN 6505017246289. The supplier must comply with technical and quality requirements referenced from the DLA Master List, and all labeling and documentation must conform to the Medical Marking Standard No. 1 and government-specific identifiers. Contract performance is tracked through detailed logistics codes, tracking numbers, and government-specific identifiers for procurement, distribution, and accountability.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Health And Human Services → Administration Services Branch

Same awarding agency